共 7 条
[1]
Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation. Segovia R,SanchezFueyo A,Rimola A,et al. Liver Transplantation . 2001
[2]
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. Feray C,Caccamo L,Alexander GJ,et al. Gastroenterology . 1999
[3]
Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after livertransplantation. Yao FY,Osorio RW,Roberts JP,et al. Liver Transplantation and Surgery . 1999
[4]
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Markowitz JS,Martin F,Conrad AJ,et al. Hepatology . 1998
[5]
Loss of serum HBSAg after interferon- a therapy in liver transplant patients with recurrent hepatitis-B infection. BenAri Z,Shmueli D,Shapira Z,et al. Liver Transplantation and Surgery . 1997
[6]
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. Marzan A,Salizzoni M,Debernardi-Venon W,et al. Journal of Hepatology . 2001
[7]
HBV vaccination and liver transplantation for hepatitis B: winning by recruiting from within. Ishitani M. Liver Transplantation . 2000